ConductScience.org, home

Paper40144468

Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.

Shinkawa H and 14 others. Liver Cancer, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study. Papers, record 40144468. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40144468

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.
PubMed
Journal
Liver Cancer
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.18, provisional
iCite
Revised in PubMed
2025-03-28
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shinkawa HHiroji
2Kaibori MMasaki
3Ueno MMasaki
4Yasuda SSatoshi
5Ikoma HHisashi
6Aihara TTsukasa
7Nakai TTakuya
8Kinoshita MMasahiko
9Kosaka HHisashi
10Hayami SShinya
11Matsuo YYasuko
12Morimura RRyo
13Nakajima TTakayoshi
14Nobori CChihoko
15Ishizawa TTakeaki

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137364790A multisociety Delphi consensus statement on new fatty liver disease nomenclature.J Hepatol2023https://conductscience.org/library/papers/37364790PubMed
218387499Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.Clin Gastroenterol Hepatol2008https://conductscience.org/library/papers/18387499PubMed
326488173
General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan.
Dig Dis2015https://conductscience.org/library/papers/26488173PubMed
437998747The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease-The Transition from an Adipocentric to Liver-Centric Approach.Curr Issues Mol Biol2023https://conductscience.org/library/papers/37998747PubMed
538264220Adipose Tissue Plasticity and Insulin Signaling in the Pathogenesis of Type 2 Diabetes.Diabetol Int2024https://conductscience.org/library/papers/38264220PubMed
616844421Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.Clin Gastroenterol Hepatol2006https://conductscience.org/library/papers/16844421PubMed
730240472Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C.J Gastrointestin Liver Dis2018https://conductscience.org/library/papers/30240472PubMed
815753540Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.Gut2005https://conductscience.org/library/papers/15753540PubMed
912502618Standards of medical care for patients with diabetes mellitus.Diabetes Care2003https://conductscience.org/library/papers/12502618PubMed
1036565361Association between diabetes and cancer. Current mechanistic insights into the association and future challenges.Mol Cell Biochem2023https://conductscience.org/library/papers/36565361PubMed
1129628281EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.J Hepatol2018https://conductscience.org/library/papers/29628281PubMed
1233442538Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update.Liver Cancer2020https://conductscience.org/library/papers/33442538PubMed
1333952449Obesity and Liver Cancer in Japan: A Comprehensive Review.Anticancer Res2021https://conductscience.org/library/papers/33952449PubMed
1411420485Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.Ann Surg2001https://conductscience.org/library/papers/11420485PubMed
1528320770High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.Gut2018https://conductscience.org/library/papers/28320770PubMed
1614726171Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.Lancet2004https://conductscience.org/library/papers/14726171PubMed
1720109902The metabolic syndrome.Lancet2010https://conductscience.org/library/papers/20109902PubMed
1826523206Era of direct acting antivirals in chronic hepatitis C: Who will benefit?World J Hepatol2015https://conductscience.org/library/papers/26523206PubMed
1920175765Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence.Aliment Pharmacol Ther2010https://conductscience.org/library/papers/20175765PubMed
2033538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed

See all 32 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42959204Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma.Glob Health Med2026https://conductscience.org/library/papers/42959204PubMed
42802761Associations of Type 2 Diabetes with Tumor Budding and Microvascular Invasion in Resected Hepatocellular Carcinoma.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42802761PubMed
42703506Metabolic burden but not metabolic dysfunction-associated steatotic liver disease affects the prognosis of patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study.J Gastrointest Oncol2026https://conductscience.org/library/papers/42703506PubMed
42630561Evidence summary on perioperative blood glucose management in liver cancer patients.Front Oncol2026https://conductscience.org/library/papers/42630561PubMed
42592470Liver reprogramming toward hepatocellular carcinoma following hepatitis C sustained virologic response: a narrative review.Transl Gastroenterol Hepatol2026https://conductscience.org/library/papers/42592470PubMed
42506450The Liver Left Behind: GLP-1 Receptor Agonists and the Prospect of Metabolic Adjuvant Therapy After HCC Resection.Metabolites2026https://conductscience.org/library/papers/42506450PubMed
42400215Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection.Kaohsiung J Med Sci2026https://conductscience.org/library/papers/42400215PubMed
42363084Development and validation of a nomogram to predict recurrence after hepatectomy in overweight patients with hepatocellular carcinoma: a retrospective cohort study.BMC Gastroenterol2026https://conductscience.org/library/papers/42363084PubMed
42045721ASO Author Reflections: Is Intervening in Metabolic Syndrome a New Direction for Improving the Prognosis After Curative-Intent Resection of Perihilar Cholangiocarcinoma?Ann Surg Oncol2026https://conductscience.org/library/papers/42045721PubMed
41896509Association Between Metabolic Syndrome and Long-Term Prognosis in Patients with Perihilar Cholangiocarcinoma Treated with Curative-Intent Resection: A Multicenter Study.Ann Surg Oncol2026https://conductscience.org/library/papers/41896509PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40144468

GET https://conductscience.org/api/papers/v1/40144468/references?page=2